A carregar...
Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma
The purpose of this study was to investigate the antitumor activity of regorafenib and sorafenib in preclinical models of HCC and to assess their mechanism of action by associated changes in protein expression in a HCC-PDX mouse model. Both drugs were administered orally once daily at 10 mg/kg (rego...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5739799/ https://ncbi.nlm.nih.gov/pubmed/29291014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22334 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|